News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe

|Videos|June 30, 2022

Multiple Sclerosis and Pregnancy Misconceptions

Author(s)Jeffrey Dunn, MD, Regina Berkovich, MD, PhD

Jeffrey Dunn, MD, and Regina Berkovich, MD, PhD, discuss misconceptions surrounding pregnancy and multiple sclerosis and highlight how to approach conversations with this patient population.

Episodes in this series

EP. 1 Multiple Sclerosis and Pregnancy Misconceptions

EP. 1 Multiple Sclerosis and Pregnancy Misconceptions

EP. 2 Considerations and Resources for Pregnant Patients With MS

EP. 2 Considerations and Resources for Pregnant Patients With MS

EP. 3 Treatment Selection in MS and Pregnancy

EP. 3 Treatment Selection in MS and Pregnancy

EP. 4 S1P Receptor Modulator Therapy Reversibility Considerations

EP. 4 S1P Receptor Modulator Therapy Reversibility Considerations

EP. 5 Postpartum Relapse in Patients With MS

EP. 5 Postpartum Relapse in Patients With MS

EP. 6 Clinical Trial Considerations for Ethnically Diverse, Underrepresented MS Patients

EP. 6 Clinical Trial Considerations for Ethnically Diverse, Underrepresented MS Patients

EP. 7 Fostering Patient-Centered Care in Ethnically Diverse, Underrepresented MS Patients

EP. 7 Fostering Patient-Centered Care in Ethnically Diverse, Underrepresented MS Patients

EP. 8 Building Trust in Ethnically Diverse and Underrepresented MS Patients

EP. 8 Building Trust in Ethnically Diverse and Underrepresented MS Patients

EP. 9 Patient Education in Ethnically Diverse and Underrepresented MS Patients

EP. 9 Patient Education in Ethnically Diverse and Underrepresented MS Patients

EP. 10 Surgical Considerations for Patients With MS

EP. 10 Surgical Considerations for Patients With MS

EP. 11 Considerations for Infection Risk in Patients With MS

EP. 11 Considerations for Infection Risk in Patients With MS

EP. 12 Immunogenicity and Disease-Modifying Therapies

EP. 12 Immunogenicity and Disease-Modifying Therapies

EP. 13 Family Planning and Vaccination Considerations for Patients With MS

EP. 13 Family Planning and Vaccination Considerations for Patients With MS

EP. 14 The Benefits of Collaborative Care for Patients With MS

EP. 14 The Benefits of Collaborative Care for Patients With MS

EP. 15 Tools and Resources for the Management of MS

EP. 15 Tools and Resources for the Management of MS

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Related Content

Brain Chat: MS or NMOSD? Why the Right Diagnosis Changes Everything

ByMitzi Joi Williams, MD

July 17th 2026

Most People With MS Who Qualify for GLP-1 Drugs Are Not Taking Them, NARCOMS Survey Finds

July 16th 2026

This Week on NeurologyLive® — July 13, 2026

ByIsabella Ciccone, MPH

July 13th 2026

Active Smoking Is Associated With Doubled Relapse Rate in MOGAD

July 11th 2026

NeurologyLive® Friday 5 — July 10, 2026

ByIsabella Ciccone, MPH

July 10th 2026

Latest CME

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Jeffrey Gudin, MD; Jeffrey Bettinger, PharmD

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Basil T. Darras, MD

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Anne M. Connolly, MD, FAAN; Amy Moore, PhD

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Karissa Gable, MD

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Zarazuela Zolkipli-Cunningham, MBChB, MRCP; Mary Kay Koenig, MD; Perry Shieh, MD, PhD, FAAN, FANA

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

James F. Howard Jr, MD, FAAN

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Jessica Oswald, MD, MPH; Jeremy A. Adler, DMSc, PA-C; Amanda Nasser, MS, NP

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

James F. Howard Jr, MD, FAAN; Katherine Ruzhansky, MD, MS

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Vinay K. Puduvalli, MD; Manmeet Ahluwalia, MD, MBA, FASCO; Girish Dhall, MD

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

Millie Das, MD; Wade Iams, MD, MSCI; Ruham Nasany, MD

Collaborating Across the Continuum™: Integrating Novel Therapies Into Multidisciplinary Treatment Plans for Generalized Myasthenia Gravis

Collaborating Across the Continuum™: Integrating Novel Therapies Into Multidisciplinary Treatment Plans for Generalized Myasthenia Gravis

Abigail Schwaede, MD; Alexis Lizarraga, MD, MS

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

James F. Howard Jr, MD, FAAN; Tuan Vu, MD

Community Collab™: Identifying the Role of Complement Inhibitors in the Management of Generalized Myasthenia Gravis

Community Collab™: Identifying the Role of Complement Inhibitors in the Management of Generalized Myasthenia Gravis

James F. Howard Jr, MD, FAAN; Tuan Vu, MD

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

Charu Aggarwal, MD, MPH, FASCO; Erminia Massarelli, MD, PhD, MS; Ruham Nasany, MD

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

POLARIS-AD Phase 3 Trial of PDE5 Inhibitor AR1001 Completes Treatment Phase With Favorable Safety Profile

Most People With MS Who Qualify for GLP-1 Drugs Are Not Taking Them, NARCOMS Survey Finds

FDA Accepts NDA for Apnimed’s AD109 for the Treatment of Obstructive Sleep Apnea

FDA Approves At-Home Starting Dose for Lecanemab, Marking First Subcutaneous Initiation Option for Alzheimer Disease Treatment

Phase 2 APPLAUDS Trial to Test Mivelsiran in Down Syndrome-Associated Alzheimer Disease